Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Using urine samples, UrSure’s tests measure the level of a med that helps prevent HIV. Here’s why that’s important.
A recent NIH study found that adults have a much higher viral suppression rate than youth.
The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.
About one in seven people living with HIV use strategies to save on drug costs, including skipping doses.
Problematic use of alcohol is likely far more common among HIV-positive people than in the general population.
Research has shown that higher wholesale cost of medication is associated with lower adherence.
A long-term study sought to determine which factors help predict low adherence among young people with the virus.
An analysis of 15,000 insured people with HIV also confirmed past findings that single-tablet regimens are associated with higher adherence.
A new study indicates that the level of adherence required for viral suppression may be lower than previously understood.
For some people with HIV treatment failure, personal difficulties with adherence may be at the root of the problem.
An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.
Generalized anxiety disorder is associated with lower rates of HIV treatment, adherence to treatment and viral suppression.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.